Full Press Release Details
ABBOTT PARK , Ill. , April 14, 2023 /PRNewswire/ -- Abbott (NYSE: ABT ) today announced that the U.S. Food and Drug Administration (FDA) has cleared a reader for its FreeStyle Libre ® 3 integrated continuous glucose monitoring (iCGM) system, which features the world's smallest, thinnest and most discreet 5 glucose sensor. With the FDA's clearance of a standalone reader, Abbott is working to get the FreeStyle Libre 3 system added to Medicare's list of covered systems as soon as possible. 3
"Our customers all over the world consistently tell us how our FreeStyle Libre technology has made an enormous, positive impact on their health and quality of life – they spend less time worrying and more time living," said Jared Watkin , senior vice president for Abbott's diabetes care business. "The FreeStyle Libre 3 reader provides more choice to people living with diabetes to have access to lifesaving technology that is smaller and easier to use and comes without the high-cost burdens of other systems."
The FreeStyle Libre 3 reader is a small handheld device that displays real-time glucose readings directly from a small sensor worn on the back of a person's upper arm, allowing them to manage their diabetes quickly and easily by viewing their glucose readings 6 on a large, bright and easy-to-see screen.
People who use the FreeStyle Libre 3 system will still have the option to use the current FreeStyle Libre 3 smartphone apps. 7,8
The reader uses a rechargeable lithium-ion battery, which is commonly found in many other electronic devices like mobile phones. The user manual for the FreeStyle Libre 3 reader provides details on how to safely store, charge and use the device, including always using the Abbott-provided USB cable and power adapter.
The FreeStyle Libre portfolio is the number one sensor-based glucose monitoring system in the world 9 , having changed the lives of 4.5 million people across more than 60 countries 10 by providing breakthrough technology that is accessible and affordable. 2
About Abbott Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.
Connect with us at www.abbott.com , on LinkedIn at www.linkedin.com/company/abbott- , on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews .